Published in Vaccine Weekly, November 8th, 1999
The CDC will contribute $2 million annually, for four years, to the selected clinics. The focus of the additional research supported by the contract is "to answer critical questions about how this and future vaccine trials may impact the attitudes and behaviors of both trial participants and the communities involved," according to the CDC.
"The CDC's support of our trial opens key avenues...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.